The Biomedical Catalyst is a grant funding mechanism that supports innovative health and care solutions, which aligns with the venture's focus on predicting drug resistance mutations. The programme's emphasis on life sciences and therapeutics also matches the venture's sector. However, the geography is limited to the UK, which may not be the primary target for the venture.